Comparison of N&H Sandwich Technique and Cesarean Hysterectomy in Management of Placenta Accreta Spectrum
1 other identifier
interventional
100
1 country
1
Brief Summary
The placenta accreta spectrum (PAS)is one of the most common reasons for cesarean hysterectomy Which associated with high rates of severe maternal morbidity (40%-50%), with reported mortality rates up to 7%. And, a cesarean hysterectomy might not be considered first-line treatment for women who have a strong desire for future fertility. Conservative management of PAS defines all procedures that aim to avoid peripartum hysterectomy and its related morbidity and consequences. The main types of conservative management which have been described in the literature: the extirpative technique (manual removal of the placenta); leaving the placenta in situ or the expectant approach; one-step conservative surgery and the Triple-P procedure. These methods have been used alone or in combination and in many cases with additional procedures such as those proposed by interventional radiology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2018
CompletedFirst Posted
Study publicly available on registry
October 10, 2018
CompletedStudy Start
First participant enrolled
November 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedDecember 13, 2018
December 1, 2018
3 years
October 5, 2018
December 11, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
intraoperative blood loss
measures the intraoperative blood loss by direct and gravimetric methods
during the operation
Secondary Outcomes (4)
postoperative blood loss
24 hours postoperative
need of blood transfusion
ist 24 hours postoperative
need of other surgical maneuvers
during the operation
operative time
during the operation
Study Arms (2)
cesarean hysterectomy
ACTIVE COMPARATORElective Cesarean hysterectomy will be planned at 37-38 weeks of gestation. An adequate amount of blood products was prepared to be available for transfusion. The operation will be performed by the same multidisciplinary team, including two expert obstetricians, an assistant, an expert anesthesiologist, and a pediatrician.
N&H sandwich technique
EXPERIMENTALIn the N\&H group, after acceptable control of bleeding from the placental bed, the internal os of the cervix was identified a double uterine compression suture at the lower uterine segment with inflated Foley's catheter balloon tamponade was performed
Interventions
Elective cesarean hysterectomy will be planned at 37-38 weeks of gestation. An adequate amount of blood products was prepared to be available for transfusion. Delivery will be performed by the same multidisciplinary team, including two expert obstetricians, an assistant, an expert anesthesiologist, and a pediatrician.
In the N\&H group, after acceptable control of bleeding from the placental bed, the internal os of the cervix was identified a double uterine compression suture at the lower uterine segment with inflated Foley's catheter balloon tamponade will be performed
Eligibility Criteria
You may qualify if:
- all pregnant women with a full-term pregnancy with placenta accreta spectrum
You may not qualify if:
- Patients with a cardiac, hepatic, renal or thromboembolic disease.
- patients with pelvic endometriosis and adnexal mass.
- those presented with severe antepartum hemorrhage will be excluded
- known coagulopathy
- twin pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aswan University
Aswān, 81528, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
hany f sallam, md
Aswan University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- no masking
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer
Study Record Dates
First Submitted
October 5, 2018
First Posted
October 10, 2018
Study Start
November 1, 2018
Primary Completion
October 30, 2021
Study Completion
January 1, 2022
Last Updated
December 13, 2018
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share